Dexelvucitabine

Dexelvucitabine

SCHEMBL599014

Nc1nc(=O)n([C@H]2C=C[C@@H](CO)O2)cc1F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

pol

The experimentally established mechanism targets of Dexelvucitabine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 4/20 0.55
LMNA P02545 6/20 0.46
ALDH1A1 P00352 2/20 0.46
BLM P54132 2/20 0.46
POLB P06746 1/20 0.46
ADRA1A P35348 1/20 0.46
POLG P54098 1/20 0.39
DCK P27707 7/20 0.35
PDE3A Q14432 3/20 0.34
PDE4D Q08499 1/20 0.34
SLC29A1 Q99808 1/20 0.34
MTOR P42345 2/20 0.34
DNMT1 P26358 2/20 0.34
THRB P10828 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
GMNN O75496 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Elvucitabine SCHEMBL3298257 1.00 ALB (0.55) ALBLMNAALDH1A1BLMPOLB
Elvucitabine SCHEMBL1649928 1.00 ALB (0.55) ALBLMNAALDH1A1BLMPOLB
SCHEMBL13770316 0.88 ALB (0.47) ALBLMNAALDH1A1BLMPOLB
SCHEMBL13594946 0.87 ALB (0.46) ALBLMNAALDH1A1BLMPOLB
SCHEMBL4749034 0.84 LMNA (0.59) ALBLMNAALDH1A1BLMPOLB
SCHEMBL5952944 0.84 LMNA (0.59) ALBLMNAALDH1A1BLMPOLB
SCHEMBL30667453 0.84 LMNA (0.46) ALBLMNAALDH1A1BLMPOLB
SCHEMBL12149532 0.84 ALB (0.44) ALBLMNAALDH1A1BLMPOLB
SCHEMBL1738785 0.82 ALB (0.43) ALBLMNAALDH1A1BLMPOLB
SCHEMBL4288548 0.82 LMNA (0.44) ALBLMNAALDH1A1BLMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6383 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144879-A1 ANTI-VIRAL AND HEPATIC-TARGETED DRUGS AI-BIOPHARMA (FR) 2026-05-28 US claimed
CN-224278664-U Rail type conveyor with protection structure Jinan Haihe Port Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-115522698-B Assembled steel structure stair and assembling method thereof HARBIN ENGINEERING UNIVERSITY (CN) 2026-05-26 CN claimed
CN-122083595-A Small-sized fruit and vegetable low-temperature instant freezer and control method thereof 2026-05-26 CN claimed
CN-224277835-U Automatic cleaning and packaging device for plastic suction tray Wuhu jinmingli logistics equipment Technology Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-224285734-U Brace rod rib alignment measuring tool LIU XIAODONG (CN) 2026-05-26 CN claimed
CN-224275249-U Carbon fiber plate processing equipment Jilin Guoxing Carbon Fiber Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-224259797-U Magnetic attraction type quick-mounting antistatic PVC coiled material 武汉砚笛实业有限公司 2026-05-19 CN claimed
CN-224255934-U Combined injection mold 无锡申博机械制造有限公司 2026-05-19 CN claimed
CN-121132164-B Semi-automatic pipe fitting alignment welding device and welding method 山东金利智能科技有限公司 2026-05-19 CN claimed
US-20070264241-A1 Compounds for Enhanced Cancer Therapy ZGENE A/S (DK) 2007-11-15 US claimed
WO-2007106450-A2 DIKETO ACIDS WITH NUCLEOBASE SCAFFOLDS: ANTI-HIV REPLICATION INHIBITORS TARGETED AT HIV INTEGRASE IN COMBINATION THERAPY UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2007-09-20 WO claimed
US-7205404-B1 Phosphorus-containing prodrugs METABASIS THERAPEUTICS, INC. (US) 2007-04-17 US claimed
US-20040167140-A1 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides EMORY UNIVERSITY 2004-08-26 US claimed
EP-1361227-A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides Emory University (US) 2003-11-12 EP claimed
US-20020198173-A1 [5-carboxamido or 5-fluoro] - [2' ,3' -unsaturated or 3' -modified] - pyrimidine nucleosides EMORY UNIVERSITY 2002-12-26 US claimed
US-6194391-B1 CS-87 (TITLE COMPOUND) INDUCES A TRANSIENT MUTATION IN HIV-1 AT THE 70TH CODON OF THE REVERSE TRANSCRIPTASE REGION OF THE VIRUS; ADMINISTERING TO A HUMAN IN NEED OF THERAPY WITH A DRUG THAT INDUCES A MUTATION IN HIV-1 AT ANOTHER LOCATION EMORY UNIVERSITY 2001-02-27 US claimed
EP-0805683-A4 5-CARBOXAMIDO OR 5-FLUORO]- 2',3'-UNSATURATED OR 3'-MODIFIED]-PYRIMIDINE NUCLEOSIDES UNIV EMORY (US) 1999-09-01 EP claimed
EP-0805683-A1 5-CARBOXAMIDO OR 5-FLUORO]- 2',3'-UNSATURATED OR 3'-MODIFIED]-PYRIMIDINE NUCLEOSIDES EMORY UNIVERSITY (US) 1997-11-12 EP claimed
WO-1996022778-A1 DERIVATIVES OF SUCCINAMIDE AND THEIR USE AS METALLOPROTEINASE INHIBITOR EMORY UNIVERSITY (US) 1996-08-01 WO claimed